Are Unsafes Drugs An 'Acceptable Risk?' FDA Should Say 'No!'
John Horton
|
Posted 05.25.2011
|
Home
Read More:
Biosimilars,
FDA Biologics,
FDA Biosimilars,
FDA Biologic Drugs,
Biosimilar Drugs,
Biologic Drugs,
Biologics,
Home News
As a matter of common sense, the FDA's process for biosimilars shouldn't sacrifice patient safety.
